BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 18766999)

  • 41. Design and practical evaluation of a shielded application system for intravenously administered radionuclide therapies.
    Kühnel C; Winkens T; Niksch T; Greiser J; Schrott S; Drescher R; Freesmeyer M
    Nuklearmedizin; 2020 Aug; 59(4):323-331. PubMed ID: 32193882
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Operational radiation safety for PET-CT, SPECT-CT, and cyclotron facilities.
    Zanzonico P; Dauer L; St Germain J
    Health Phys; 2008 Nov; 95(5):554-70. PubMed ID: 18849690
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Radiation protection of PFMA-1, a plasma focus for medical applications.
    Fabbri A; Frignani M; Mannucci S; Mostacci D; Rocchi F; Sumini M; Teodori F; Angeli E; Tartari A; Cucchi G
    J Radiol Prot; 2007 Dec; 27(4):465-70. PubMed ID: 18268377
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Standardization of (67)Ga using a 4pi(LS)beta-gamma anti-coincidence system.
    Bobin C; Bouchard J; Hamon C; Iroulart MG; Plagnard J
    Appl Radiat Isot; 2007 Jul; 65(7):757-63. PubMed ID: 17379531
    [TBL] [Abstract][Full Text] [Related]  

  • 45. A compilation of microdosimetry for uniformly distributed Auger emitters used in medicine.
    Chen J
    Int J Radiat Biol; 2008 Dec; 84(12):1027-33. PubMed ID: 19061126
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [Radiation exposure in the environment of patients after application of radiopharmaceuticals. Part 2: Therapeutic procedures].
    Sudbrock F; Boldt F; Kobe C; Hammes J; Eschner W; Schicha H
    Nuklearmedizin; 2009; 48(1):17-25. PubMed ID: 19212607
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Rapid determination of (90)Sr impurities in freshly "generator eluted"(90)Y for radiopharmaceutical preparation.
    Bonardi ML; Martano L; Groppi F; Chinol M
    Appl Radiat Isot; 2009 Oct; 67(10):1874-7. PubMed ID: 19628401
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Influence of radiation source geometry on determination of (111)In and (90)Y activity of radiopharmaceuticals.
    Peitl PK; Tomse P; Kroselj M; Socan A; Hojker S; Pecar S; Stopar TG
    Nucl Med Commun; 2009 Oct; 30(10):807-14. PubMed ID: 19623093
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Absorbed fractions in ellipsoidal volumes for beta(-) radionuclides employed in internal radiotherapy.
    Amato E; Lizio D; Baldari S
    Phys Med Biol; 2009 Jul; 54(13):4171-80. PubMed ID: 19521004
    [TBL] [Abstract][Full Text] [Related]  

  • 50. An experimental attenuation plate to improve the dose distribution in intraoperative electron beam radiotherapy for breast cancer.
    Oshima T; Aoyama Y; Shimozato T; Sawaki M; Imai T; Ito Y; Obata Y; Tabushi K
    Phys Med Biol; 2009 Jun; 54(11):3491-500. PubMed ID: 19436105
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Do angles of obliquity apply to 30 degrees scattered radiation from megavoltage beams?
    Biggs PJ; Styczynski JR
    Health Phys; 2008 Oct; 95(4):425-32. PubMed ID: 18784515
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Cardiac catheterization: impact of face and neck shielding on new estimates of effective dose.
    von Boetticher H; Lachmund J; Hoffmann W
    Health Phys; 2009 Dec; 97(6):622-7. PubMed ID: 19901597
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Radiological risk assessment of Capstone depleted uranium aerosols.
    Hahn FF; Roszell LE; Daxon EG; Guilmette RA; Parkhurst MA
    Health Phys; 2009 Mar; 96(3):352-62. PubMed ID: 19204491
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Excitation functions of (alpha,xn) reactions on (nat)Rb and (nat)Sr from threshold up to 26 MeV: possibility of production of (87)Y, (88)Y and (89)Zr.
    Kandil SA; Spahn I; Scholten B; Saleh ZA; Saad SM; Coenen HH; Qaim SM
    Appl Radiat Isot; 2007 May; 65(5):561-8. PubMed ID: 17344051
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Skin dose calculations for uranium fuel particles below 500 microns in diameter.
    Pöllänen R; Toivonen H
    Health Phys; 1995 Mar; 68(3):401-5. PubMed ID: 7860313
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [Radiation protection during radioiodine treatment (author's transl)].
    Müller-Duysing W
    Schweiz Rundsch Med Prax; 1982 Apr; 71(16):694-8. PubMed ID: 7111189
    [No Abstract]   [Full Text] [Related]  

  • 57. [Protection of eye lens in computed tomography--dose evaluation on an anthropomorphic phantom using thermo-luminescent dosimeters and Monte-Carlo simulations].
    Keil B; Wulff J; Schmitt R; Auvanis D; Danova D; Heverhagen JT; Fiebich M; Madsack B; Leppek R; Klose KJ; Zink K
    Rofo; 2008 Dec; 180(12):1047-53. PubMed ID: 19235699
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [Radiation protection for personnel in the diagnostic application of radioactive material: guidelines in the handling of radioactive agents].
    Ennow K
    Sygeplejersken; 1979 Sep; 79(37):12-7. PubMed ID: 260396
    [No Abstract]   [Full Text] [Related]  

  • 59. Fluoroscopically guided percutaneous vertebroplasty: assessment of radiation doses and implementation of procedural routines to reduce operator exposure.
    von Wrangel A; Cederblad A; Rodriguez-Catarino M
    Acta Radiol; 2009 Jun; 50(5):490-6. PubMed ID: 19363715
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Usefulness of non-lead aprons in radiation protection for physicians performing interventional procedures.
    Zuguchi M; Chida K; Taura M; Inaba Y; Ebata A; Yamada S
    Radiat Prot Dosimetry; 2008; 131(4):531-4. PubMed ID: 18801753
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.